Yahoo
OTC Markets OTCQB - Delayed Quote USD

Izotropic Corporation (IZOZF)

0.0880 +0.0080 (+10.00%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for IZOZF
  • Previous Close 0.0800
  • Open 0.1000
  • Bid 0.0865 x 2000000
  • Ask 0.0890 x 3000000
  • Day's Range 0.1000 - 0.1000
  • 52 Week Range 0.0740 - 0.3000
  • Volume 7,500
  • Avg. Volume 25,032
  • Market Cap (intraday) 6.365M
  • Beta (5Y Monthly) 2.48
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 0.83
  • Moby Rating Neutral

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a breast CT imaging system. The company was incorporated in 2016 and is headquartered in Surrey, Canada.

izocorp.com

--

Full Time Employees

April 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

IZOZF
57.07%
S&P/TSX Composite index (^GSPTSE)
12.31%

1-Year Return

IZOZF
72.33%
S&P/TSX Composite index (^GSPTSE)
18.89%

3-Year Return

IZOZF
20.00%
S&P/TSX Composite index (^GSPTSE)
80.53%

5-Year Return

IZOZF
87.78%
S&P/TSX Composite index (^GSPTSE)
66.80%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue --
Earnings --
Profit Margin 0.00%

Q3

FY26

Q4

FY26

Q1

FY27

0
0.0%

Analyst Insights

View More

Analyst Price Targets

0.83
0.83 Average
0.0880 Current
0.83 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -366.51%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -2.29M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    57.78k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -424.17k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: